Edition:
United Kingdom

Rxi Pharmaceuticals Corp (RXII.OQ)

RXII.OQ on NASDAQ Stock Exchange Capital Market

0.43USD
22 Oct 2018
Change (% chg)

-- (--)
Prev Close
$0.43
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
127,082
52-wk High
$7.60
52-wk Low
$0.41

Select another date:

Fri, May 18 2018

BRIEF-Rxi Pharmaceuticals Announces Positive Results From Phase 2 Trial With Samcyprone For Treatment Of Common Warts

* RXI PHARMACEUTICALS ANNOUNCES POSITIVE RESULTS FROM PHASE 2 TRIAL WITH SAMCYPRONE™ FOR THE TREATMENT OF COMMON WARTS

BRIEF-RXI Pharmaceuticals Says Selling Stockholders Are Offering On A Resale Basis An Aggregate Of 1.2 Million Shares Of Co's Common Stock

* RXI PHARMACEUTICALS CORP SAYS SELLING STOCKHOLDERS ARE OFFERING ON A RESALE BASIS AN AGGREGATE OF 1.2 MILLION SHARES OF CO'S COMMON STOCK - SEC FILING Source text: (https://bit.ly/2IbzxKR) Further company coverage:

BRIEF-RXi Pharmaceuticals Announces Grant Of Patent From USPTO For sd-rxRNAs To Treat Fibrotic Disorders

* RXI PHARMACEUTICALS - GRANTED PATENT FROM USPTO FOR METHODS OF USE OF SD-RXRNAS TARGETING CONNECTIVE TISSUE GROWTH FACTOR TO TREAT FIBROTIC DISORDERS Source text for Eikon: Further company coverage:

Select another date: